Literature DB >> 8095307

Different requirements for membrane fusion mediated by the envelopes of human immunodeficiency virus types 1 and 2.

T Dragic1, M Alizon.   

Abstract

CD4+ cells derived from the human cell lines U87MG and SCL1 cannot be infected by human immunodeficiency virus type 1 (HIV-1) or fuse with cells expressing the HIV-1 envelope. This block was complemented in heterokaryons with HeLa cells and probably reflects the absence of cellular factors necessary for membrane fusion. Since U87MG cells expressing CD4 are permissive to HIV-2, distinct cellular factors could be required for fusion mediated by two related human retroviruses.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8095307      PMCID： PMC240396     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  18 in total

1.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

2.  Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells.

Authors:  P A Ashorn; E A Berger; B Moss
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4.

Authors:  J P Moore
Journal:  AIDS       Date:  1990-04       Impact factor: 4.177

4.  Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients.

Authors:  M Alizon; S Wain-Hobson; L Montagnier; P Sonigo
Journal:  Cell       Date:  1986-07-04       Impact factor: 41.582

5.  Genome organization and transactivation of the human immunodeficiency virus type 2.

Authors:  M Guyader; M Emerman; P Sonigo; F Clavel; L Montagnier; M Alizon
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

6.  Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells.

Authors:  B Chesebro; R Buller; J Portis; K Wehrly
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

7.  The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule.

Authors:  Q J Sattentau; P R Clapham; R A Weiss; P C Beverley; L Montagnier; M F Alhalabi; J C Gluckmann; D Klatzmann
Journal:  AIDS       Date:  1988-04       Impact factor: 4.177

8.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

9.  Cellular factors regulate transactivation of human immunodeficiency virus type 1.

Authors:  P A Barry; E Pratt-Lowe; R E Unger; P A Luciw
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1.

Authors:  M Emerman; M Guyader; L Montagnier; D Baltimore; M A Muesing
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598
View more
  20 in total

1.  Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups.

Authors:  M T Dittmar; G Simmons; S Hibbitts; M O'Hare; S Louisirirotchanakul; S Beddows; J Weber; P R Clapham; R A Weiss
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 2.  Chemokine receptors and chemokines in HIV infection.

Authors:  A Garzino-Demo; A L DeVico; R C Gallo
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

3.  Exceptional fusogenicity of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process.

Authors:  D C Siess; S L Kozak; D Kabat
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

4.  Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.

Authors:  G Alkhatib; C C Broder; E A Berger
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

Review 5.  Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.

Authors:  Andrew W Woodham; Joseph G Skeate; Adriana M Sanna; Julia R Taylor; Diane M Da Silva; Paula M Cannon; W Martin Kast
Journal:  AIDS Patient Care STDS       Date:  2016-07       Impact factor: 5.078

6.  CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia.

Authors:  H Blaak; P H M Boers; R A Gruters; H Schuitemaker; M E van der Ende; A D M E Osterhaus
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1.

Authors:  R Merat; H Raoul; T Leste-Lasserre; P Sonigo; G Pancino
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry.

Authors:  B C Herold; I Scordi-Bello; N Cheshenko; D Marcellino; M Dzuzelewski; F Francois; R Morin; V Mas Casullo; R A Anderson; C Chany; D P Waller; L J D Zaneveld; M E Klotman
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

9.  Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line.

Authors:  R D Harrington; A P Geballe
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Dissociation of the CD4 and CXCR4 binding properties of human immunodeficiency virus type 1 gp120 by deletion of the first putative alpha-helical conserved structure.

Authors:  D Missé; M Cerutti; I Schmidt; A Jansen; G Devauchelle; F Jansen; F Veas
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.